A citation-based method for searching scientific literature

Maria Esposito, Alessandro Giunta, Annamaria Mazzotta, Arianna Zangrilli, Graziella Babino, Mauro Bavetta, Roberto Perricone, Sergio Chimenti, Maria Sole Chimenti. Dermatology 2012
Times Cited: 54







List of co-cited articles
515 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Efficacy and safety of systemic treatments for psoriasis in elderly patients.
Stefano Piaserico, Andrea Conti, Francesco Lo Console, Clara De Simone, Francesca Prestinari, Annamaria Mazzotta, Giulio Gualdi, Claudio Guarneri, Stefania Borsari, Nicoletta Cassano. Acta Derm Venereol 2014
57
35

Efficacy and safety of ustekinumab treatment in elderly patients with psoriasis.
Mitsuha Hayashi, Yoshinori Umezawa, Osamu Fukuchi, Toshihiro Ito, Hidehisa Saeki, Hidemi Nakagawa. J Dermatol 2014
47
36

Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis.
Alan Menter, Kenneth B Gordon, Craig L Leonardi, Yihua Gu, Orin M Goldblum. J Am Acad Dermatol 2010
107
29

Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period.
M Megna, M Napolitano, N Balato, G Monfrecola, A Villani, F Ayala, A Balato. Clin Exp Dermatol 2016
30
53

Etanercept for the treatment of psoriasis in the elderly.
Giuseppe Militello, Amy Xia, Seth R Stevens, Abby S Van Voorhees. J Am Acad Dermatol 2006
31
48

Managing moderate-to-severe psoriasis in the elderly.
Nicola Balato, Cataldo Patruno, Maddalena Napolitano, Angela Patrì, Fabio Ayala, Raffaele Scarpa. Drugs Aging 2014
39
35

Efficacy and safety of infliximab in psoriatic patients over the age of 65.
Andrea Chiricozzi, Athanasios Pavlidis, Annunziata Dattola, Luca Bianchi, Maria Sole Chimenti, Monika Fida, Rosita Saraceno. Expert Opin Drug Saf 2016
16
87

Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation.
Ivan S Grozdev, Abby S Van Voorhees, Alice B Gottlieb, Sylvia Hsu, Mark G Lebwohl, Bruce F Bebo, Neil J Korman. J Am Acad Dermatol 2011
36
36

Efficacy and Safety of Secukinumab in Elderly Subjects with Moderate to Severe Plaque Psoriasis: A Pooled Analysis of Phase III Studies.
Andreas Körber, Charis Papavassilis, Vaishali Bhosekar, Maximilian Reinhardt. Drugs Aging 2018
31
38

Global epidemiology of psoriasis: a systematic review of incidence and prevalence.
Rosa Parisi, Deborah P M Symmons, Christopher E M Griffiths, Darren M Ashcroft. J Invest Dermatol 2013
18

Biologic treatments for elderly patients with psoriasis.
Mami Momose, Akihiko Asahina, Mitsuha Hayashi, Koichi Yanaba, Yoshinori Umezawa, Hidemi Nakagawa. J Dermatol 2017
22
45

Classification criteria for psoriatic arthritis: development of new criteria from a large international study.
William Taylor, Dafna Gladman, Philip Helliwell, Antonio Marchesoni, Philip Mease, Herman Mielants. Arthritis Rheum 2006
16


Elderly psoriatic patients under biological therapies: an Italian experience.
F Ricceri, F Bardazzi, A Chiricozzi, P Dapavo, F Ferrara, C Mugheddu, M Romanelli, F Rongioletti, F Prignano. J Eur Acad Dermatol Venereol 2019
17
52

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Alan Menter, Alice Gottlieb, Steven R Feldman, Abby S Van Voorhees, Craig L Leonardi, Kenneth B Gordon, Mark Lebwohl, John Y M Koo, Craig A Elmets, Neil J Korman,[...]. J Am Acad Dermatol 2008
858
14

Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials.
Ignacio Garcia-Doval, Gregorio Carretero, Francisco Vanaclocha, Carlos Ferrandiz, Esteban Daudén, Jose-Luis Sánchez-Carazo, Mercé Alsina, Enrique Herrera-Ceballos, Francisco-José Gómez-García, Marta Ferrán,[...]. Arch Dermatol 2012
123
14

The safety of anti-TNF agents in the elderly.
A Migliore, E Bizzi, B Laganà, L Altomonte, G Zaccari, M Granata, M Canzoni, B Marasini, M Massarotti, U Massafra,[...]. Int J Immunopathol Pharmacol 2009
27
29

Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.
C Medina, G Carretero, C Ferrandiz, E Dauden, F Vanaclocha, F J Gómez-García, E Herrera-Ceballos, P De la Cueva-Dobao, I Belinchón, J L Sánchez-Carazo,[...]. J Eur Acad Dermatol Venereol 2015
34
23

Biologic and Conventional Systemic Therapies Show Similar Safety and Efficacy in Elderly and Adult Patients With Moderate to Severe Psoriasis.
Caren Garber, Natalia Plotnikova, Shiu-chung Au, Eric P Sorensen, Alice Gottlieb. J Drugs Dermatol 2015
22
36

Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
Stephen Tyring, Kenneth B Gordon, Yves Poulin, Richard G Langley, Alice B Gottlieb, Meleana Dunn, Angelika Jahreis. Arch Dermatol 2007
251
12

Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study.
A Chiricozzi, A Zangrilli, M Bavetta, L Bianchi, S Chimenti, R Saraceno. J Eur Acad Dermatol Venereol 2017
21
33

Psoriatic arthritis.
J M Moll, V Wright. Semin Arthritis Rheum 1973
787
11

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.
Alan Menter, Stephen K Tyring, Kenneth Gordon, Alexa B Kimball, Craig L Leonardi, Richard G Langley, Bruce E Strober, Martin Kaul, Yihua Gu, Martin Okun,[...]. J Am Acad Dermatol 2008
629
11

Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study.
M Esposito, P Gisondi, N Cassano, G Ferrucci, M Del Giglio, F Loconsole, A Giunta, G A Vena, S Chimenti, G Girolomoni. Br J Dermatol 2013
112
11

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis.
Christopher E M Griffiths, Bruce E Strober, Peter van de Kerkhof, Vincent Ho, Roseanne Fidelus-Gort, Newman Yeilding, Cynthia Guzzo, Yichuan Xia, Bei Zhou, Shu Li,[...]. N Engl J Med 2010
620
11

Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
Robert E Kalb, David F Fiorentino, Mark G Lebwohl, John Toole, Yves Poulin, Arnon D Cohen, Kavitha Goyal, Steven Fakharzadeh, Stephen Calabro, Marc Chevrier,[...]. JAMA Dermatol 2015
218
11


Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis.
C Phan, M-L Sigal, E Estève, Z Reguiai, H Barthélémy, N Beneton, F Maccari, M Lahfa, D Thomas-Beaulieu, T Le Guyadec,[...]. J Eur Acad Dermatol Venereol 2016
28
21

Safety of selective IL-23p19 inhibitors for the treatment of psoriasis.
J J Crowley, R B Warren, J C Cather. J Eur Acad Dermatol Venereol 2019
37
16

Biologic Treatment in Elderly Patients With Psoriasis: A Systematic Review.
Vijay Kumari Sandhu, Arvin Ighani, Patrick Fleming, Charles W Lynde. J Cutan Med Surg 2020
13
46

Clinical response in psoriasis patients discontinued from and then reinitiated on etanercept therapy.
Kenneth B Gordon, Alice B Gottlieb, Craig L Leonardi, Boni E Elewski, Andrea Wang, Angelika Jahreis, Ralph Zitnik. J Dermatolog Treat 2006
90
9

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).
J-H Saurat, G Stingl, L Dubertret, K Papp, R G Langley, J-P Ortonne, K Unnebrink, M Kaul, A Camez. Br J Dermatol 2008
528
9

Treatment recommendations for psoriatic arthritis.
C T Ritchlin, A Kavanaugh, D D Gladman, P J Mease, P Helliwell, W-H Boehncke, K de Vlam, D Fiorentino, O Fitzgerald, A B Gottlieb,[...]. Ann Rheum Dis 2009
377
9

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics.
Alice Gottlieb, Neil J Korman, Kenneth B Gordon, Steven R Feldman, Mark Lebwohl, John Y M Koo, Abby S Van Voorhees, Craig A Elmets, Craig L Leonardi, Karl R Beutner,[...]. J Am Acad Dermatol 2008
311
9

European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies.
L Gossec, J S Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, D van der Heijde, O FitzGerald, D Aletaha, P Balint, D Boumpas,[...]. Ann Rheum Dis 2012
339
9

Etanercept as monotherapy in patients with psoriasis.
Craig L Leonardi, Jerold L Powers, Robert T Matheson, Bernard S Goffe, Ralph Zitnik, Andrea Wang, Alice B Gottlieb. N Engl J Med 2003
885
9

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).
Kim A Papp, Richard G Langley, Mark Lebwohl, Gerald G Krueger, Philippe Szapary, Newman Yeilding, Cynthia Guzzo, Ming-Chun Hsu, Yuhua Wang, Shu Li,[...]. Lancet 2008
9


[Systematic review: safety and efficacy of anti-TNF in elderly patients].
Noemi Busquets, Loreto Carmona, Xavier Surís. Reumatol Clin 2011
17
29


Methotrexate dosage in patients aged over 50 with psoriasis.
G M Fairris, A G Dewhurst, J E White, M J Campbell. BMJ 1989
21
23



Secukinumab in plaque psoriasis--results of two phase 3 trials.
Richard G Langley, Boni E Elewski, Mark Lebwohl, Kristian Reich, Christopher E M Griffiths, Kim Papp, Lluís Puig, Hidemi Nakagawa, Lynda Spelman, Bárður Sigurgeirsson,[...]. N Engl J Med 2014
9

Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study.
Ian Landells, Colleen Marano, Ming-Chun Hsu, Shu Li, Yaowei Zhu, Lawrence F Eichenfield, Peter H Hoeger, Alan Menter, Amy S Paller, Alain Taieb,[...]. J Am Acad Dermatol 2015
124
9

European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC.
A Nast, P Gisondi, A D Ormerod, P Saiag, C Smith, P I Spuls, P Arenberger, H Bachelez, J Barker, E Dauden,[...]. J Eur Acad Dermatol Venereol 2015
275
9

Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
E Daudén, L Puig, C Ferrándiz, J L Sánchez-Carazo, J M Hernanz-Hermosa. J Eur Acad Dermatol Venereol 2016
61
9

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.
Mark Lebwohl, Bruce Strober, Alan Menter, Kenneth Gordon, Jolanta Weglowska, Lluis Puig, Kim Papp, Lynda Spelman, Darryl Toth, Francisco Kerdel,[...]. N Engl J Med 2015
487
9




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.